Drug Profile
NEO 201
Alternative Names: 16C3 antibody; h16C3 monoclonal antibody; NEO-201Latest Information Update: 16 Apr 2024
Price :
$50
*
At a glance
- Originator Precision Biologics
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Apoptosis stimulants; Natural killer cell stimulants; Regulatory T-lymphocyte modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Cervical cancer; Head and neck cancer; Non-small cell lung cancer; Uterine cancer
- Phase I Solid tumours
- Preclinical Gynaecological cancer